Friday, May 22, 2015 1:25:00 PM
I concur.
Do not forget the fundamentals and the time needed to get this company on track. Most of all go back a week and look at what happened, especially the share volume, the price movement and the DUMB MONEY.
Do not forget the fundamentals and the time needed to get this company on track. Most of all go back a week and look at what happened, especially the share volume, the price movement and the DUMB MONEY.
Recent CATX News
- Perspective Therapeutics to Present Data from All Clinical Programs at the 2026 ASCO Annual Meeting, including Findings from [212Pb]VMT01 in Melanoma • GlobeNewswire Inc. • 05/21/2026 09:51:13 PM
- Perspective Therapeutics Announces First Patients Dosed in New Cohorts of Two Ongoing Phase 1/2a Studies • GlobeNewswire Inc. • 05/18/2026 10:30:00 AM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 05/12/2026 04:47:39 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/11/2026 08:13:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/11/2026 08:10:44 PM
- Perspective Therapeutics Provides Recent Business Highlights and Reports 1Q 2026 Results • GlobeNewswire Inc. • 05/11/2026 08:07:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/04/2026 08:43:03 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 04/27/2026 08:12:23 PM
- Perspective Therapeutics to Provide Several Upcoming Corporate Updates • GlobeNewswire Inc. • 04/24/2026 10:30:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/20/2026 10:05:00 AM
- Perspective Therapeutics Presents Updated Interim Data of [212Pb]VMT-α-NET in Its Ongoing Phase 1/2a Clinical Trial at the 2026 AACR Annual Meeting • GlobeNewswire Inc. • 04/20/2026 10:00:00 AM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/16/2026 08:10:52 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/16/2026 08:10:05 PM
- Perspective Therapeutics to Participate in Upcoming Investor Conferences • GlobeNewswire Inc. • 04/02/2026 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/01/2026 08:16:31 PM
- Perspective Therapeutics Announces Acceptance of VMT-α-NET Data for Presentation at the AACR Annual Meeting 2026 • GlobeNewswire Inc. • 03/17/2026 08:45:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/16/2026 08:12:49 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/16/2026 08:10:36 PM
- Perspective Therapeutics Provides Recent Business Highlights and Reports Full Year 2025 Results • GlobeNewswire Inc. • 03/16/2026 08:07:00 PM
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 03/11/2026 12:36:50 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2026 09:38:30 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2026 09:38:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2026 09:37:44 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2026 09:37:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2026 09:35:45 PM
